CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award Chief Financial Officer acquired 4,994 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 32,810 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 23,697 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 23,697 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Scientific Officer gave up 418 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 21 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 29,634 shares (to pay taxes)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K/A Event Results of operations
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change
Page 5 of 104 · 2,077 filings